Hikma Pharmaceuticals (HIK)

Sector: Pharma and Biotech     Index: FTSE 100
-0.95%
-19.00p
1,981.00p
10:00 29/03/17
1,981.00p
10:00 29/03/17
DAILY VARIATION
-0.95%
-19.00p
VOLUME
56,342
REAL TIME BATS
1,985.00p
00:00 28/02/10
-0.55%
-11.00p
DATA
52 Week High
2,676.00p
52 Week Low
1,624.00p
Shares Issued
239.97m
Market Cap
£4,753.89m
RiskGrade
156
Beta
0.69
MENU

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 1.3% 1.3%
Div Cover 3.6 4.0
Op Mrgn 15.5% 18.1%
ROCE 19.3%
Latest F'cast
P/E 21.1 19.1
PEG -1.2 1.7
Pr/Revenue 3.1 2.7
Pr/Book 2.5
Latest F'cast
Revenue 35.4% 4.2%
PBT -34.0% n/a
EPS -17.5% -10.4%
DPS 3.1% 5.7%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,109.00 132.00 61.40¢ 20.2 1.1 18% 16.00¢ 1.3%
2013-12-31 1,365.00 298.00 139.10¢ 14.3 0.1 127% 20.00¢ 1.0%
2014-12-31 1,489.00 362.00 151.00¢ 20.4 2.4 9% 22.00¢ 0.7%
2015-12-31 1,440.00 318.00 143.70¢ 23.6 -4.9 -5% 32.00¢ 0.9%
2016-12-31 1,950.00 210.00 118.50¢ 19.7 -1.1 -18% 33.00¢ 1.4%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 1,782.53 321.93 105.24p 19.1 1.7 11% 26.21p 1.3%
2018-12-31 1,956.23 407.91 134.40p 15.6 0.6 28% 31.06p 1.6%

Regulatory News

slide to see more
Holding(s) in Company 27-Mar-17 11:15
Director/PDMR Shareholding 23-Mar-17 09:31
Final Results 15-Mar-17 07:05

Newspaper Links

No results found